Athersys Inc (NASDAQ:ATHX)

0.5906
Delayed Data
As of Nov 28
 +0.013 / +2.24%
Today’s Change
0.50
Today|||52-Week Range
33.25
-97.38%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$7.5M

Company Description

Athersys, Inc. engages in the discovery and development of therapies designed to extend and enhance to quality of human life. It offers MultiStem as its stem cell product which provides biological potency and therapeutic effects for distinct diseases and conditions in the cardiovascular, neurological, inflammatory, and immune disease areas. The company was founded by John J. Harrington and Gil van Bokkelen on October 24, 1995 and is headquartered in Cleveland, OH.

Contact Information

Athersys, Inc.
3201 Carnegie Avenue
Cleveland Ohio 44115-2634
P:(216) 431-9900
Investor Relations:

Employees

Shareholders

Mutual fund holders7.22%
Individual stakeholders3.68%
Other institutional11.09%

Top Executives

Daniel A. CamardoChief Executive Officer, Secretary, Director & CAO
Maia A. HansenChief Operating Officer
Kasey RosadoChief Financial Officer
Rakesh RamachandranHead-Information Technology & Communications
Manal MorsyExecutive VP & Head-Global Regulatory Affairs